house · trading 2016-03-14 → 2026-03-31
*Notional-weighted price return on disclosed buys from the last ~3 years, marked to the latest close — open positions, per-share (share counts aren't disclosed, so this is price performance, not realized $ P&L).
By recent-buy return, Harold Dallas Rogers ranks #45 of 122 lawmakers — better than 63% of Congress.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-31 | SPY | BUY | $1K–$15K | $650.34 | $771.10 2026-08-27 | +18.6% |
| 2025-11-24 | T | SELL | $1K–$15K | $25.62 | $25.43 2026-08-27 | +0.7% exit |
| 2024-05-09 | VWO | SELL | $1K–$15K | $43.37 | $61.01 2026-08-27 | -18.3% rt |
| 2024-05-09 | IVV | SELL | $1K–$15K | $522.66 | $774.75 2026-08-27 | +3.3% rt |
| 2024-05-09 | IJS | SELL | $1K–$15K | $100.98 | $138.04 2026-08-27 | +6.7% rt |
| 2024-05-09 | BBL | SELL | $1K–$15K | — | — | — exit |
| 2024-04-16 | VWO | BUY | $1K–$15K | $40.83 | $61.01 2026-08-27 | +49.4% |
| 2024-04-16 | IVV | BUY | $1K–$15K | $505.98 | $774.75 2026-08-27 | +53.1% |
| 2024-04-16 | IJS | BUY | $1K–$15K | $94.66 | $138.04 2026-08-27 | +45.8% |
| 2024-04-16 | IEMG | BUY | $1K–$15K | $50.04 | $82.42 2026-08-27 | +64.7% |
| 2024-04-16 | BGL | BUY | $1K–$15K | — | — | — |
| 2024-04-16 | BGB | BUY | $1K–$15K | $11.67 | $11.17 2026-08-27 | -4.3% |
| 2024-04-16 | BBL | BUY | $1K–$15K | — | — | — |
| 2024-03-31 | SPY | BUY | $1K–$15K | $523.07 | $771.10 2026-08-27 | +47.4% |
| 2021-03-25 | GSK | BUY | $1K–$15K | $36.07 | $50.27 2026-08-27 | +39.4% |
| 2021-03-16 | VWO | BUY | $1K–$15K | $53.07 | $61.01 2026-08-27 | +15.0% |
| 2021-03-16 | K | BUY | $1K–$15K | — | — | — |
| 2021-03-16 | GSK | BUY | $1K–$15K | $36.35 | $50.27 2026-08-27 | +38.3% |
| 2021-03-16 | BND | BUY | $1K–$15K | $84.74 | $72.54 2026-08-27 | -14.4% |
| 2017-09-11 | HCA | BUY | $1K–$15K | $78.35 | $419.34 2026-08-27 | +435.2% |
| 2017-09-07 | ZOET | BUY | $1K–$15K | — | — | — |
| 2017-09-07 | O | BUY | $1K–$15K | $56.89 | $61.80 2026-08-27 | +8.6% |
| 2016-03-24 | QCOM | BUY | $1K–$15K | $50.86 | $164.78 2026-08-27 | +224.0% |
| 2016-03-24 | PYPL | BUY | $1K–$15K | $38.92 | $61.47 2026-08-27 | +57.9% |
| 2016-03-15 | ROK | BUY | $1K–$15K | $107.18 | $433.00 2026-08-27 | +304.0% |
| 2016-03-15 | BROWN | BUY | $1K–$15K | — | — | — |
| 2016-03-14 | MRK | BUY | $1K–$15K | $50.65 | $149.54 2026-08-27 | +195.3% |
Return: buys are marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (how the stock moved after the sale, seller's perspective).
| Member | Shared tickers |
|---|---|
| Thomas R Carper | 8 · GSK, IEMG, IJS, IVV, PYPL, QCOM |
| Kurt Schrader | 8 · GSK, VWO, IJS, T, PYPL, QCOM |
| James B. Renacci | 7 · GSK, IVV, T, MRK, PYPL, QCOM |
| John Boozman | 7 · BND, GSK, VWO, IVV, PYPL, QCOM |
| Kenny Marchant | 7 · GSK, K, T, MRK, QCOM, HCA |
| David A Perdue , Jr | 6 · T, MRK, PYPL, QCOM, HCA, SPY |
| Alan S. Lowenthal | 6 · IEMG, T, MRK, PYPL, HCA, SPY |
| Josh Gottheimer | 6 · T, MRK, PYPL, ROK, HCA, SPY |
| Thomas H Tuberville | 6 · GSK, IVV, MRK, PYPL, QCOM, ROK |
| Alan Armstrong | 6 · T, MRK, PYPL, QCOM, HCA, O |
| Charles J. "Chuck" Fleischmann | 6 · BND, GSK, IEMG, IJS, PYPL, SPY |
| Mike Kelly | 6 · GSK, VWO, T, HCA, O, SPY |